Skip to main content

ProShare Advisors LLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1357955 BETHESDA, MD

Position in APLS

as of Mar 31, 2026 · filed Apr 27, 2026
Position Value
$0
+$0 QoQ
Shares Held
6,809
-5.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 6,809
2024-09-30 7,197
2024-06-30 7,492
2024-03-31 8,452
2023-12-31 7,571
2023-09-30 7,692
2023-06-30 7,535
2023-03-31 18,974
2022-12-31 22,637
2022-09-30 21,068
2022-06-30 18,510
2022-03-31 23,745
2021-12-31 29,151
2021-09-30 26,894
2021-06-30 31,313
2021-03-31 27,179
2020-12-31 24,993
2020-09-30 19,547
2020-06-30 20,227
2020-03-31 13,656